Aleksandr V Kudriavtsev (Aleksandr Kudriavtsev)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Extracorporeal Membrane Oxygenation

Top Venues

International reviews of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksandr V Kudriavtsev, Anna V Vakhrusheva, Nickolay A Kryuchkov, Maria E Frolova, Konstantin A Blagodatskikh, Taras V Ivanishin, Milana Djonovic, Ekaterina A Romanovskaya-Romanko, Anton N Kovalenko, Dmitry A Lioznov, Tatiana G Zubkova, Svetlana V Teplykh, Rodion A Oseshnyuk, Marina A Stukova, Artur A Isaev, Igor V Krasilnikov
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial. Vaccines 11 (2) (2023)
Aleksandr V Kudriavtsev, Anna V Vakhrusheva, Nickolay A Kryuchkov, Maria E Frolova, Konstantin A Blagodatskikh, Taras V Ivanishin, Milana Djonovic, Ekaterina A Romanovskaya-Romanko, Anton N Kovalenko, Dmitry A Lioznov, Tatiana G Zubkova, Svetlana V Teplykh, Rodion A Oseshnyuk, Marina A Stukova, Artur A Isaev, Igor V Krasilnikov
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial. Vaccines 11 (2) (2023)
Aleksandr V Kudriavtsev, Anna V Vakhrusheva, Valery N Novosеletsky, Marine E Bozdaganyan, Konstantin V Shaitan, Mikhail P Kirpichnikov, Olga S Sokolova
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics. Viruses 14 (8) (2022)
Anna V Vakhrusheva, Aleksandr V Kudriavtsev, Nickolay A Kryuchkov, Roman V Deev, Maria E Frolova, Konstantin А Blagodatskikh, Milana Djonovic, Andrey Anatolevich Nedorubov, Elena Odintsova, Aleksandr V Ivanov, Ekaterina A Romanovskaya-Romanko, Marina A Stukova, Artur A Isaev, Igor V Krasilnikov
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study. Vaccines 10 (8) (2022)
Alex Shneider, Aleksandr V Kudriavtsev, Anna V Vakhrusheva
Can melatonin reduce the severity of COVID-19 pandemic? International reviews of immunology 39 (4) (2020)